Literature DB >> 35612709

P2X receptors in the balance between inflammation and pathogen control in sepsis.

Luiz Eduardo Baggio Savio1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35612709      PMCID： PMC9391544          DOI： 10.1007/s11302-022-09870-6

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN： 1573-9538            Impact factor:   3.950


× No keyword cloud information.
  26 in total

Review 1.  Immunomodulatory effects of P2X7 receptor in intracellular parasite infections.

Authors:  Luiz Eduardo Baggio Savio; Robson Coutinho-Silva
Journal:  Curr Opin Pharmacol       Date:  2019-03-20       Impact factor: 5.547

2.  Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors.

Authors:  L H Jiang; A B Mackenzie; R A North; A Surprenant
Journal:  Mol Pharmacol       Date:  2000-07       Impact factor: 4.436

Review 3.  The immunopathology of sepsis and potential therapeutic targets.

Authors:  Tom van der Poll; Frank L van de Veerdonk; Brendon P Scicluna; Mihai G Netea
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

Review 4.  Update of P2Y receptor pharmacology: IUPHAR Review 27.

Authors:  Kenneth A Jacobson; Esmerilda G Delicado; Christian Gachet; Charles Kennedy; Ivar von Kügelgen; Beibei Li; M Teresa Miras-Portugal; Ivana Novak; Torsten Schöneberg; Raquel Perez-Sen; Doreen Thor; Beili Wu; Zhenlin Yang; Christa E Müller
Journal:  Br J Pharmacol       Date:  2020-04-06       Impact factor: 9.473

5.  Extracellular ATP drives systemic inflammation, tissue damage and mortality.

Authors:  A Cauwels; E Rogge; B Vandendriessche; S Shiva; P Brouckaert
Journal:  Cell Death Dis       Date:  2014-03-06       Impact factor: 8.469

Review 6.  The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?

Authors:  Luiz E B Savio; Paola de Andrade Mello; Cleide Gonçalves da Silva; Robson Coutinho-Silva
Journal:  Front Pharmacol       Date:  2018-02-06       Impact factor: 5.810

7.  Targeting Purinergic Signaling in the Dynamics of Disease Progression in Sepsis.

Authors:  Raíssa Leite-Aguiar; Vinícius Santos Alves; Luiz Eduardo Baggio Savio; Robson Coutinho-Silva
Journal:  Front Pharmacol       Date:  2021-01-14       Impact factor: 5.810

Review 8.  Update of P2X receptor properties and their pharmacology: IUPHAR Review 30.

Authors:  Peter Illes; Christa E Müller; Kenneth A Jacobson; Thomas Grutter; Annette Nicke; Samuel J Fountain; Charles Kennedy; Günther Schmalzing; Michael F Jarvis; Stanko S Stojilkovic; Brian F King; Francesco Di Virgilio
Journal:  Br J Pharmacol       Date:  2020-12-21       Impact factor: 9.473

9.  Pulmonary infection with hypervirulent Mycobacteria reveals a crucial role for the P2X7 receptor in aggressive forms of tuberculosis.

Authors:  Eduardo P Amaral; Simone C M Ribeiro; Verônica R Lanes; Fabrício M Almeida; Marcelle R M de Andrade; Caio Cesar Barbosa Bomfim; Erika M Salles; Karina R Bortoluci; Robson Coutinho-Silva; Mario H Hirata; José M Alvarez; Elena B Lasunskaia; Maria Regina D'Império-Lima
Journal:  PLoS Pathog       Date:  2014-07-03       Impact factor: 6.823

10.  Overexpressed CD39 mitigates sepsis‑induced kidney epithelial cell injury via suppressing the activation of NLR family pyrin domain containing 3.

Authors:  Meixia Yang; Linxin Lu; Zhiqin Kang; Tianlong Ma; Yu Wang
Journal:  Int J Mol Med       Date:  2019-09-23       Impact factor: 4.101
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.